HALIFAX, Canada, January 23 /PRNewswire/ -- ImmunoVaccine Technologies Inc. (IVT) announced today that it has met with Health Canada's regulatory affairs division, the Biologics and Genetic Therapies Directorate, to discuss requirements for a Phase I clinical trial application. For Phase I human clinical trials, IVT plans to combine novel antigens with its vaccine-enhancement technology, the VacciMax(R) platform.

"We are seeing impressive pre-clinical results with the VacciMax(R) platform," said Dr. Randal Chase, president and CEO of IVT. "The comments from the Biologics and Genetic Therapies Directorate are much appreciated because they give us direction as we proceed with our clinical development in Canada," said Dr. Chase.

REDWOOD CITY, California, January 23 /PRNewswire/ --

Codexis, Inc., a private biotechnology company and leading developer of clean manufacturing processes, today announced the opening of Codexis Laboratories Hungary Kft (CLH) in Budapest.

IRVINE, California and LONDON, January 23 /PRNewswire/ --

- Logibanque Solution Helps Groupe Moniteur Quickly Evolve to SaaS Offering

Endeavors Technologies, the pioneer in application streaming and virtualization technology, and its parent company, Tadpole Technology plc, today announced Wallace Systems has incorporated AppExpress into its Logibanque software distribution and management system. Wallace Systems has implemented its first large-scale deployment of Logibanque at Groupe Moniteur in France, enabling Groupe Moniteur to immediately offer its extensive information catalogs via a web-based system and avoid a time consuming, expensive move to web 2.0 technologies.

LONDON, January 23 /PRNewswire/ --

- With photo

LONDON, January 23 /PRNewswire/ --

Ellen Thomas, best known for her role as Liz Webbe in the Channel 4 hit series Teachers, will be a celebrity judge for a new GBP10,000 Creme of Nature Community Grant Award scheme; available to African Caribbean organisations or groups, working with black women in the UK. The application process, which launched in November 2007, is already under-way with a deadline for receipt of applications set for 31st January 2008.

MONTREAL and CAMBRIDGE, England, January 23 /PRNewswire/ --

- First Phase of Development of Product to Reduce Risk of Variant Creutzfeldt-Jakob Disease From Plasma Product Completed on Schedule

- Scale-Up Phase Worth US$1 M to ProMetic

- Multi-Million Dollar Long-Term Agreement to Supply Prion Removal Affinity Resin Following Regulatory Approval Anticipated by Mid-2008

BANGALORE, India, January 23 /PRNewswire/ --

- GlobalEdge Enhances its Design Capabilities in Delivering Residential and SOHO CPE Solutions

GlobalEdge Software Ltd., a leading embedded software solutions and services company today announced its partnership with Mindspeed(R) Technologies Inc. (NASDAQ:MSPD), a leading supplier of semiconductor solutions for network infrastructure applications, to deliver high performance software solutions around Mindspeed's Comcerto(R) broadband gateway processors.